Eledon Pharmaceuticals, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:ELDN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -16.06 M-17.71 M-14.48 M-14.09 M-22.61 M -68.89 M Cash from investing activities 3.89 M14.96 M12.4 M-20.46 M5.96 M 12.86 M Cash from financing activities 115 K0053.69 M115 K — Free cash flow -16.06 M-17.71 M-14.48 M-14.09 M-22.61 M -68.89 M

News

Medical Services Name Tests For Colon Cancer. Natera Stock Hits A High.

Eledon Pharmaceuticals, Inc. (ELDN) Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation - Slideshow (NASDAQ:ELDN) 2026-06-22

Is Eledon Pharmaceuticals (ELDN) Outperforming Other Medical Stocks This Year?

Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug - NewcelX (NASDAQ:NCEL)

Leerink Partners reiterates Outperform on Eledon stock at $5

Eledon reports insulin independence in islet transplant trial

NewcelX partners with Eledon on type 1 diabetes therapy

Eledon Pharmaceuticals at Guggenheim Summit: Tegoprubart’s Promising Path

Eledon reports positive 24-month kidney transplant data for tegoprubart

Eledon’s tegoprubart shows promise in kidney transplantation trials

Eledon Pharmaceuticals stock rises after positive islet transplant data